Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002041883 | SCV002108447 | pathogenic | Qualitative or quantitative defects of dysferlin | 2020-11-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with DYSF-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu1981Thrfs*16) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). |
Baylor Genetics | RCV003470950 | SCV004194233 | likely pathogenic | Miyoshi muscular dystrophy 1 | 2023-08-12 | criteria provided, single submitter | clinical testing |